 |
Case Series
Management of Covid-19 in the outpatient setting
1 Owner, Empire NY Medical Care, New York, NY, USA
2 Nurse Practitioner, Owner, Empire NY Medical Care, New York, NY, USA
Address correspondence to:
Weymin Hago
MD, 450 Park Ave S Suite 202, New York, NY 10016,
USA
Message to Corresponding Author
Article ID: 100087Z06WH2020
Access full text article on other devices
Access PDF of article on other devices
How to cite this article
Hago W, Amen M. Management of Covid-19 in the outpatient setting. Case Rep Int 2020;9:100087Z06WH2020.ABSTRACT
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus that is responsible for the current infection known as coronavirus disease 2019 (Covid-19). SARS-CoV-2 was first discovered on December 2019 in Wuhan, Hubei Province, China, and led the World Health Organization (WHO) to declare it a public health emergency on January 30, 2020. By reviewing the pathophysiology of SARS-CoV-2 we can better understand the patient’s symptoms in conjunction with imaging findings seen in moderate illness Covid-19 patients. In these case studies we demonstrate the benefit of using acetazolamide for patients with moderate illness.
Case Series: We present two cases of Covid-19 patients exhibiting moderate illness. Both patients received antibiotics in the first two weeks of illness with improvement of dry cough and fever; however, they subsequently developed shortness of breath. The imaging findings of both patients revealed infiltrates of the lower lobes. The patients were treated with acetazolamide leading to clinical improvement.
Conclusion: Moderate illness Covid-19 patients who present with pulmonary edema can benefit from the use of acetazolamide from the effects of diuresis and changes in pH.
Keywords: Acetazolamide, Covid-19, SARS-CoV-2 treatment
SUPPORTING INFORMATION
Acknowledgments
Chris Palmero, MD, Fernando Soto Avellanet, MD
Author ContributionsWeymin Hago - Substantial contributions to conception and design, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Meulan Amen - Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Guaranter of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patients for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest.
Copyright© 2020 Weymin Hago et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.
